Clinical features and therapeutic response of thyroid associated ophthalmopathy during COVID-19 pandemic

Clinical features and therapeutic response of thyroid associated ophthalmopathy during COVID-19 pandemic - Clinical features and therapeutic response of thyroid associated ophthalmopathy during COVID-19 pandemic

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000054544

Enrollment

Registered

2024-10-01

Start date

2023-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid associated ophthalmopathy

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients from 20 to 90 years old diagnosed with active thyroid associated ophthalmopathy

Exclusion criteria

Exclusion criteria: Patients who have indicated their refusal to participate in the study

Design outcomes

Primary

Measure	Time frame
Clinical features at diagnosis therapeutic response of clinical activity score and diplopia at 6 months after	—

Countries

Japan

Contacts

Public ContactKazuhiko Matsuzawa

Tottori University Faculty of Medicine Division of Pharmacology

k.matsuzawa@tottori-u.ac.jp+81-859-38-6517

Outcome results